• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Advaxis, Inc. (ADXS)

    -NasdaqCM
    5.61 Up 0.75(15.43%) 4:00PM EST
    |After Hours : 5.95 Up 0.34 (6.06%) 6:47PM EST
    Add to Portfolio
    Prev Close:4.86
    Open:4.86
    Bid:5.42 x 500
    Ask:N/A
    1y Target Est:11.67
    Beta:2.5
    Next Earnings Date:N/A
    Day's Range:4.71 - 5.79
    52wk Range:2.46 - 5.99
    Volume:652,265
    Avg Vol (3m):194,253
    Market Cap:109.50M
    P/E (ttm):N/A
    EPS (ttm):-1.47
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ADXS

    Comparison

    Symbol% ChgMkt Cap
    ADXSUp 15.43%109.50M
    BVTI 0.00%N/A
    DNDN 0.00%N/A
    VICL 0.00%96.65M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):94.86
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Oct-14) :-1.13
    Quarterly EPS Est (Oct-14) :-0.31
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Advaxis, Inc., a clinical development stage biotechnology company, focuses on developing immunotherapies for cancer and infectious diseases. The company’s Lm -LLO immunotherapy platform technology stimulates the immune system to induce antige... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback